6.3 C
New York
Saturday, March 25, 2023

Latest Posts

Modern test to combine its anti-COVID vaccine and a specific one against omicron

The American pharmaceutical company Moderna announced this Thursday that it has started clinical trials with a booster vaccine against COVID-19 that combines its original formula with a specific one in response to the omicron variant.

In a statement, the company said it plans to involve some 375 people who had already received two doses of the vaccine and a booster dose in this second phase of the study, which is being carried out in the United States.

These tests are in addition to those that Moderna is doing only with a specific booster dose to combat omicron, which it announced last January.

Our goal has been to stay ahead of the virus and we are committed to continuing to generate and share data with public health authorities as they prepare for the fall booster season.”, pointed out in the note the CEO, Stephane Bancel.

Bancel He pointed out that the messenger RNA technology on which the vaccine is based allows changes to be made quickly as variants of the virus emerge.

Like modernPfizer and BioNTech they are also conducting trials with a possible booster dose designed to be more effective against omicron.

Source: Gestion


Latest Posts

Don't Miss

Stay in touch

To be updated with all the latest news, offers and special announcements.